Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Zika circulation, congenital syndrome, and current guidelines

making sense of it all for the traveller

Chen, Lin H.a , b; Wilson, Mary E.c , d

Current Opinion in Infectious Diseases: October 2019 - Volume 32 - Issue 5 - p 381–389
doi: 10.1097/QCO.0000000000000575
TROPICAL AND TRAVEL-ASSOCIATED DISEASES: Edited by Christina Coyle
Buy

Purpose of review Zika virus (ZIKV) swept through the Americas and led to recognition of its neurotropism. Zika circulation elsewhere in the world, nonvector transmission including maternal–fetal/sexual/transfusion routes, and additional reports on congenital Zika syndrome (CZS) and Guillain–Barré syndrome (GBS) have been published.

Recent findings In 2018–2019, ZIKV transmission occurred in Cuba, India, and is suspected to appear sporadically in other countries. Maternal–fetal ZIKV transmission appears to occur in about 26% of ZIKV-infected pregnant women. The US ZIKV Pregnancy and Infant Registry identified 6% of live births to have at least one ZIKV-associated birth defect; 9% had at least one neurodevelopmental abnormality; 1% had both. Infectious virus was rarely isolated from semen of ZIKV-infected male patients beyond day 38 after symptom onset. Brazilian blood donations had low ZIKV prevalence in 2015–2016; in the United States, screening donations was cost-effective only in the high mosquito season in Puerto Rico.

Summary ZIKV transmission continues; many countries with competent mosquitoes are at risk. Transmission can occur without detection where surveillance is poor and laboratory capacity limited. Travelers are important sentinels. Variations exist among ZIKV strains and Aedes mosquitoes that influence competence for transmission. Maternal–fetal transmission results in significant rates of abnormality. Identification of infectious virus in semen clarifies sexual transmission risk, with updated recommendations for preconception planning. ZIKV neurotropism requires further research and long-term follow-up.

aDivision of Infectious Diseases and Travel Medicine, Mount Auburn Hospital, Cambridge

bHarvard Medical School

cDepartment of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, Massachusetts

dDepartment of Epidemiology and Biostatistics, School of Medicine, University of California, San Francisco, USA

Correspondence to Lin H. Chen, MD, Division of Infectious Diseases and Travel Medicine, Mount Auburn Hospital, 330 Mount Auburn Street, Cambridge, MA 02138, USA,. Tel: +1 617 499 5026; fax: +1 617 499 5453; e-mail: lchen@hms.harvard.edu

Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.